2016 Research Leaders: Leading corporate institutions in Nature & Science

The 2016 Research Leaders are based on Nature Index data from 1 January 2015 to 31 December 2015.

Table criteria

Position Institution Share 2015 Count 2015
1 F. Hoffmann-La Roche AG, Switzerland 8.56 14
2 IBM, United States of America (USA) 3.14 7
3 Novartis AG, Switzerland 2.72 12
4 Merck & Co., Inc., United States of America (USA) 2.70 6
5 Bristol-Myers Squibb (BMS), United States of America (USA) 1.69 3
6 Alphabet Inc., United States of America (USA) 1.42 3
7 Amgen Inc., United States of America (USA) 1.03 5
8 BGI, China 1.03 11
9 Cellular Research, Inc., United States of America (USA) 1.00 1
9 Daiichi Sankyo Co., Ltd., Japan 1.00 1
10 Johnson & Johnson, United States of America (USA) 0.86 4
11 Meta Platforms, Inc., United States of America (USA) 0.83 1
12 Ionis Pharmaceuticals, Inc., United States of America (USA) 0.82 3
13 Gilead Sciences, Inc., United States of America (USA) 0.77 1
14 D. E. Shaw Research, United States of America (USA) 0.77 2
15 Carbon3D, Inc., United States of America (USA) 0.74 1
16 Samsung Group, South Korea 0.71 2
17 Sanofi, France 0.68 3
18 Natera, Inc., United States of America (USA) 0.67 1
19 GNS Science, New Zealand 0.64 4
20 Leidos Holdings, Inc., United States of America (USA) 0.61 10
21 Profectus Biosciences, Inc., United States of America (USA) 0.58 2
22 Pfizer Inc., United States of America (USA) 0.56 2
23 GSK, United Kingdom (UK) 0.51 6
24 BASF SE, Germany 0.51 3
25 Tekmira Pharmaceuticals Corp., Canada 0.50 1
26 NovoBiotic Pharmaceuticals, LLC, United States of America (USA) 0.48 1
27 Pacific Biosciences of California, Inc., United States of America (USA) 0.45 2
28 Sir Marcus Fernando Mawatha, Sri Lanka 0.44 1
29 Illumina, Inc., United States of America (USA) 0.38 4
30 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 0.35 3
31 Microsoft Corporation, United States of America (USA) 0.29 4
32 UCB S.A., Belgium 0.29 2
33 AnimalScan Advanced Veterinary Imaging, United States of America (USA) 0.27 1
34 Orion Genomics, United States of America (USA) 0.26 1
35 Nippon Telegraph and Telephone Corporation (NTT), Japan 0.25 1
35 Fluidigm Corporation, United States of America (USA) 0.25 1
35 JenaBatteries GmbH, Germany 0.25 1
36 Sangamo Therapeutics Inc., United States of America (USA) 0.24 1
37 Protiva Biotherapeutics, Inc., Canada 0.23 1
38 Cadre Research Labs (CRL), United States of America (USA) 0.22 1
39 Boehringer Ingelheim, Germany 0.22 1
40 Azimuth Corporation, United States of America (USA) 0.20 1
41 Global Phasing Limited, United Kingdom (UK) 0.18 1
41 Ecopetrol S.A., Colombia 0.18 1
42 Tempero Pharmaceuticals, United States of America (USA) 0.18 1
43 Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.17 1
44 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 0.17 1
44 European Spallation Source ESS AB, Sweden 0.17 1
45 Symphogen A/S, Denmark 0.15 2

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences and health sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 145 natural-science and health-science journals. The journals were selected on reputation by an independent panel of leading scientists in their fields. The list is reviewed periodically and journals may be removed or added. Articles from eLife were no longer included in the Nature Index from 2023 after the journal changed its publishing model.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen research leaders.